Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Malignant Lymphoma

  Free Subscription

Articles published in J Natl Cancer Inst

Retrieve available abstracts of 7 articles:
HTML format

Single Articles

    January 2023
  1. JONES RR, Fisher JA, Medgyesi DN, Buller ID, et al
    Ethylene oxide emissions and incident breast cancer and non-Hodgkin lymphoma in a U.S. cohort.
    J Natl Cancer Inst. 2023 Jan 12:djad004. doi: 10.1093.
    PubMed     Abstract available

    August 2022
  2. SUNG H, Siegel RL, Hyun N, Miller KD, et al
    Subsequent Primary Cancer Risk Among 5-Year Survivors of Adolescent and Young Adult Cancers.
    J Natl Cancer Inst. 2022;114:1095-1108.
    PubMed     Abstract available

    June 2022
  3. ROBERTI S, van Leeuwen FE, Ronckers CM, Krul IM, et al
    Radiotherapy-related dose and irradiated volume effects on breast cancer risk among Hodgkin lymphoma survivors.
    J Natl Cancer Inst. 2022 Jun 30. pii: 6623416. doi: 10.1093.
    PubMed     Abstract available

  4. CASTILHO JL, Bian A, Jenkins CA, Shepherd BE, et al
    CD4/CD8 Ratio and Cancer Risk Among Adults With HIV.
    J Natl Cancer Inst. 2022;114:854-862.
    PubMed     Abstract available

    July 2021
  5. JANELSINS MC, Mohamed M, Peppone LJ, Magnuson A, et al
    Longitudinal Changes in Cognitive Function in a Nationwide Cohort Study of Patients with Lymphoma Treated with Chemotherapy.
    J Natl Cancer Inst. 2021 Jul 13. pii: 6320069. doi: 10.1093.
    PubMed     Abstract available

  6. VARDY JL, Fardell J
    Understanding Longitudinal Changes in Cognitive Function in Lymphoma Patients: Where to Next?
    J Natl Cancer Inst. 2021 Jul 13. pii: 6320068. doi: 10.1093.

    May 2021
  7. FIDLER-BENAOUDIA MM, Oeffinger KC, Yasui Y, Robison LL, et al
    A Comparison of Late Mortality Among Survivors of Childhood Cancer in the United States and United Kingdom.
    J Natl Cancer Inst. 2021;113:562-571.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.